BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18704032)

  • 1. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis.
    Pulver LS; Hopfenbeck MM; Young PC; Stoddard GJ; Korgenski K; Daly J; Byington CL
    J Perinatol; 2009 Jan; 29(1):20-5. PubMed ID: 18704032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
    Schrag SJ; Verani JR
    Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal group B streptococcus infection, neonatal outcome and the role of preventive strategies.
    Elvedi-Gasparović V; Peter B
    Coll Antropol; 2008 Mar; 32(1):147-51. PubMed ID: 18494200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of early-onset Group B Streptococcal disease - the Northern Ireland experience.
    Eastwood KA; Craig S; Sidhu H; Boyle M; Gannon C; Ong G; Lupari M; Craven A; Magowan S; Ashe RG
    BJOG; 2015 Feb; 122(3):361-7. PubMed ID: 24861487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of universal antenatal screening for group B streptococcus.
    Van Dyke MK; Phares CR; Lynfield R; Thomas AR; Arnold KE; Craig AS; Mohle-Boetani J; Gershman K; Schaffner W; Petit S; Zansky SM; Morin CA; Spina NL; Wymore K; Harrison LH; Shutt KA; Bareta J; Bulens SN; Zell ER; Schuchat A; Schrag SJ
    N Engl J Med; 2009 Jun; 360(25):2626-36. PubMed ID: 19535801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.
    Konrad G; Katz A
    Can Fam Physician; 2007 Jun; 53(6):1055, 2001:e.1-6, 1054. PubMed ID: 17872785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approach.
    Berardi A; Lugli L; Baronciani D; Rossi C; Ciccia M; Creti R; Gambini L; Mariani S; Papa I; Tridapalli E; Vagnarelli F; Ferrari F;
    Pediatr Infect Dis J; 2010 Feb; 29(2):115-21. PubMed ID: 19915512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
    Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
    J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of universal maternal screening on the incidence of neonatal early-onset group B streptococcal disease.
    Eberly MD; Rajnik M
    Clin Pediatr (Phila); 2009 May; 48(4):369-75. PubMed ID: 18832528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the effect of the introduction of antenatal screening for group B
    Bevan D; White A; Marshall J; Peckham C
    BMJ Open; 2019 Mar; 9(3):e024324. PubMed ID: 30904850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in early-onset group B beta hemolytic streptococcus disease with changing recommendations for prophylaxis.
    Uy IP; D'Angio CT; Menegus M; Guillet R
    J Perinatol; 2002; 22(7):516-22. PubMed ID: 12368965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of early-onset neonatal group B streptococcal infection: is universal screening by culture universally applicable?
    Eisenberg VH; Raveh D; Meislish Y; Rudensky B; Ezra Y; Samueloff A; Eidelman AI; Schimmel MS
    Isr Med Assoc J; 2006 Oct; 8(10):698-702. PubMed ID: 17125117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of perinatal group B streptococcal disease in Minnesota: results from a retrospective cohort study and new prevention guidelines.
    Ogunmodede F; Virnig BA; Danila R; Lynfield R
    Minn Med; 2003 Aug; 86(8):40-5. PubMed ID: 12959179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study to prevent early-onset Group B Streptococcal disease in newborns.
    Jefferson UT
    Adv Neonatal Care; 2006 Aug; 6(4):208-19. PubMed ID: 16890133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is neonatal group B streptococcal infection preventable?
    Azam M; Allen NM; O'Donovan D; Moylett E
    Ir Med J; 2011 May; 104(5):149-51. PubMed ID: 21736092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of different prevention strategies on neonatal group B streptococcal disease.
    Vergani P; Patanè L; Colombo C; Borroni C; Giltri G; Ghidini A
    Am J Perinatol; 2002 Aug; 19(6):341-8. PubMed ID: 12357426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of a screening program for the prevention of neonatal early-onset group B Streptococcus infection: a population-based cohort study in Inner Mongolia, China.
    Ji Y; Zhao C; Ma XX; Peppelenbosch MP; Ma Z; Pan Q
    J Med Microbiol; 2019 May; 68(5):803-811. PubMed ID: 30994439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group B streptococcus disease in neonates: to screen or not to screen?
    Subair O; Wagner P; Omojole F; Morgan H
    J Obstet Gynaecol; 2005 Jul; 25(5):462-4. PubMed ID: 16183581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.